BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6202973)

  • 1. Effects of dopamine receptor agonists and antagonists at peripheral neuronal and vascular dopamine receptors in the anaesthetised dog.
    Hilditch A; Drew GM
    J Cardiovasc Pharmacol; 1984; 6(3):460-9. PubMed ID: 6202973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of dopamine receptor agonists and antagonists at peripheral neuronal and vascular dopamine receptors in the anaesthetised cat.
    Dallas S; Drew GM; Hilditch A
    J Cardiovasc Pharmacol; 1986; 8(1):116-25. PubMed ID: 2419673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of presynaptic receptors in the cardiovascular actions of N,N-di-n-propyldopamine in the cat and dog.
    Massingham R; Dubocovich ML; Langer SZ
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Oct; 314(1):17-28. PubMed ID: 7442823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of the dopamine receptors in the rabbit isolate splenic artery.
    Hilditch A; Drew GM
    Eur J Pharmacol; 1981 Jul; 72(4):287-96. PubMed ID: 7274328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in peripheral and central dopamine receptor sensitivity after subchronic treatment with fluphenazine and sulpiride.
    Hietala J; MacDonald E; Syvälahti E; Scheinin M
    Pharmacol Toxicol; 1987 Jul; 61(1):48-52. PubMed ID: 3628181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood pressure lowering effects of N,N-di-n-propyl-dopamine in rats: evidence for stimulation of peripheral dopamine receptors leading to inhibition of sympathetic vascular tone.
    Cavero I; Lefèvre-Borg F; Gomeni R
    J Pharmacol Exp Ther; 1981 Aug; 218(2):515-24. PubMed ID: 7252851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the cardiovascular actions of N,N-di-n-propyl dopamine and sodium nitroprusside in conscious and chloralose-anaesthetised dogs.
    O'Connor SE; Smith GW; Brown RA
    J Cardiovasc Pharmacol; 1982; 4(3):493-9. PubMed ID: 6177948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of DA-1- and DA-2-dopamine antagonists on apomorphine-induced inhibition of peripheral sympathetic neurotransmission.
    Hietala J
    J Auton Pharmacol; 1988 Dec; 8(4):297-302. PubMed ID: 2855331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of dopamine and its agonists and antagonists on the receptive field properties of ganglion cells in the rabbit retina.
    Jensen RJ; Daw NW
    Neuroscience; 1986 Mar; 17(3):837-55. PubMed ID: 3703255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N,N-Di-n-propyl dopamine: a qualitatively different dopamine vascular agonist.
    Kohli JD; Goldberg LI; Volkman PH; Cannon JG
    J Pharmacol Exp Ther; 1978 Oct; 207(1):16-22. PubMed ID: 702336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the enantiomers of 3-PPP on DA1 and DA2 dopamine receptors in the dog.
    Kohli JD; Glock D; Goldberg LI
    Eur J Pharmacol; 1985 Aug; 114(3):305-10. PubMed ID: 4065203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of peripheral dopamine receptors in rats: a mechanism for novel antihypertensive agents.
    Lefèvre-Borg F; Cavero I
    Clin Sci (Lond); 1980 Dec; 59 Suppl 6():291s-294s. PubMed ID: 7449273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine receptors in human basilar arteries.
    Forster C; Drew GM; Hilditch A; Whalley ET
    Eur J Pharmacol; 1983 Feb; 87(2-3):227-35. PubMed ID: 6573262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine-like renal and mesenteric vasodilation caused by apomorphine 6-propylnorapomorphine and 2-amino-6, 7-dihydroxy-1,2,3,4-tetrahydronaphthalene.
    Crumly HJ; Pinder RM; Hinshaw WB; Goldberg LI
    Nature; 1976 Feb; 259(5544):584-7. PubMed ID: 1250405
    [No Abstract]   [Full Text] [Related]  

  • 15. Blockade of dopamine receptors in the renal vasculature by isomers of flupenthixol and sulpiride.
    Schmidt M; Imbs JL; Giesen EM; Schwartz J
    J Cardiovasc Pharmacol; 1983; 5(1):86-9. PubMed ID: 6186865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in apomorphine-induced stereotypy as a result of subacute neuroleptic treatment correlates with increased D-2 receptors, but not with increases in D-1 receptors.
    Fleminger S; Rupniak NM; Hall MD; Jenner P; Marsden CD
    Biochem Pharmacol; 1983 Oct; 32(19):2921-7. PubMed ID: 6138043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prejunctional dopamine receptors modulate twitch responses to parasympathetic nerve stimulation in the rabbit isolated rectococcygeus muscle.
    Drew GM; Hilditch A
    Br J Pharmacol; 1984 Dec; 83(4):871-81. PubMed ID: 6151412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of dopamine, apomorphine and piribedil on the mesenterial blood flow of the cat.
    György L; Dóda M
    Arch Int Pharmacodyn Ther; 1985 May; 275(1):22-32. PubMed ID: 4026462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The actions of antipsychotic drugs on dopamine receptors in the rat substantia nigra.
    Pinnock RD
    Br J Pharmacol; 1984 Apr; 81(4):631-5. PubMed ID: 6144343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine-sensitive adenylate cyclase in homogenates of rat nucleus accumbens: structure-activity studies and effects of agonists and antagonists.
    Watling KJ; Woodruff GN; Poat JA
    Eur J Pharmacol; 1979 Jun; 56(1-2):45-9. PubMed ID: 38129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.